Your browser doesn't support javascript.
loading
Changing the paradigm: Elimination - Not only of cervical cancer.
Bornstein, Jacob; Sacinti, Koray Gorkem; Preti, Mario; Billan, Salem; Razeghian, Hosna; Stockdale, Colleen K.
  • Bornstein J; The Research Institute of Galilee Medical Center, Galilee Medical Center, Nahariya, Israel.
  • Sacinti KG; Department of Obstetrics and Gynecology, Azrieli Faculty of Medicine of Bar-Ilan University, Nahariya, Israel.
  • Preti M; Department of Obstetrics and Gynecology, Ankara University School of Medicine, Ankara, Turkey.
  • Billan S; Division of Epidemiology, Department of Public Health, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Razeghian H; Department of Surgical Sciences, University of Torino, Torino, Italy.
  • Stockdale CK; Department of Oncology and Radiation, Head and Neck Center, Rambam Health Care Campus, Israel Institute of Technology, Haifa 31096, Israel.
Gynecol Oncol Rep ; 54: 101445, 2024 Aug.
Article en En | MEDLINE | ID: mdl-39045263
ABSTRACT
The WHO's initiative to eliminate cervical cancer by 2030 does not address the increasing incidence of vulvar, anal, and oropharyngeal cancers linked to high-risk HPV. Currently, the prevention of these three cancers faces various obstacles, such as a lack of specialized screening programs, well-defined management guidelines, and widespread public awareness. Without any interventions, the incidence of these three cancers will likely rise in the upcoming years, increasingly affecting younger individuals. We recommend expanding the WHO's initiative to include vulvar, anal, and oropharyngeal cancers. This involves developing screening and management protocols similar to those for cervical cancer, implementing gender-neutral HPV vaccination programs, establishing clear referral pathways to specialized centers, promoting public awareness, and providing education to healthcare providers and high-risk individuals.
Palabras clave